BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24933002)

  • 1. Common variants of xeroderma pigmentosum genes and prostate cancer risk.
    Mirecka A; Paszkowska-Szczur K; Scott RJ; Górski B; van de Wetering T; Wokołorczyk D; Gromowski T; Serrano-Fernandez P; Cybulski C; Kashyap A; Gupta S; Gołąb A; Słojewski M; Sikorski A; Lubiński J; Dębniak T
    Gene; 2014 Aug; 546(2):156-61. PubMed ID: 24933002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
    Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
    Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum genes and melanoma risk.
    Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
    Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
    Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
    Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
    J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
    Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
    Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome.
    Santiago SP; Junior HLR; de Sousa JC; de Paula Borges D; de Oliveira RTG; Farias IR; Costa MB; Maia ARS; da Nóbrega Ito M; Magalhães SMM; Pinheiro RF
    Leuk Res; 2017 Jul; 58():73-82. PubMed ID: 28472728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
    Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study.
    Dhillon VS; Yeoh E; Fenech M
    Urol Oncol; 2011; 29(6):641-6. PubMed ID: 19914098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of XPD polymorphisms with prostate cancer in Taiwanese patients.
    Bau DT; Wu HC; Chiu CF; Lin CC; Hsu CM; Wang CL; Wang RF; Tsai FJ
    Anticancer Res; 2007; 27(4C):2893-6. PubMed ID: 17695467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
    Ma Q; Qi C; Tie C; Guo Z
    Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPD common variants and their association with melanoma and breast cancer risk.
    Debniak T; Scott RJ; Huzarski T; Byrski T; Masojć B; van de Wetering T; Serrano-Fernandez P; Górski B; Cybulski C; Gronwald J; Debniak B; Maleszka R; Kładny J; Bieniek A; Nagay L; Haus O; Grzybowska E; Wandzel P; Niepsuj S; Narod SA; Lubinski J
    Breast Cancer Res Treat; 2006 Jul; 98(2):209-15. PubMed ID: 16685590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
    Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
    Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
    Hsieh YY; Chang CC; Wang YK; Hsu KH; Chen CP; Hsu CM; Tsai FJ
    Anticancer Res; 2010 Jun; 30(6):2203-8. PubMed ID: 20651370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.